BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dai G, Yu L, Yang J, Xia K, Zhang Z, Liu G, Gao T, Guo W. The synergistic antitumor effect of cinobufagin and cisplatin in human osteosarcoma cell line in vitro and in vivo. Oncotarget 2017;8:85150-68. [PMID: 29156710 DOI: 10.18632/oncotarget.19554] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Ren W, Chen S, Liao Y, Li S, Ge J, Tao F, Huo Q, Zhang Y, Zhao Z. Near-infrared fluorescent carbon dots encapsulated liposomes as multifunctional nano-carrier and tracer of the anticancer agent cinobufagin in vivo and in vitro. Colloids Surf B Biointerfaces 2019;174:384-92. [PMID: 30476792 DOI: 10.1016/j.colsurfb.2018.11.041] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
2 Deng LJ, Li Y, Qi M, Liu JS, Wang S, Hu LJ, Lei YH, Jiang RW, Chen WM, Qi Q, Tian HY, Han WL, Wu BJ, Chen JX, Ye WC, Zhang DM. Molecular mechanisms of bufadienolides and their novel strategies for cancer treatment. Eur J Pharmacol 2020;887:173379. [PMID: 32758567 DOI: 10.1016/j.ejphar.2020.173379] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Yang A, Wu Q, Chen Q, Yang J, Li H, Tao Y, Wang A, Sun Y, Zhang J. Cinobufagin restrains the growth and triggers DNA damage of human hepatocellular carcinoma cells via proteasome-dependent degradation of thymidylate synthase. Chemico-Biological Interactions 2022;360:109938. [DOI: 10.1016/j.cbi.2022.109938] [Reference Citation Analysis]
4 Kurman Y, Kiliccioglu I, Dikmen AU, Esendagli G, Bilen CY, Sozen S, Konac E. Cucurbitacin B and cisplatin induce the cell death pathways in MB49 mouse bladder cancer model. Exp Biol Med (Maywood) 2020;245:805-14. [PMID: 32252554 DOI: 10.1177/1535370220917367] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Pan Z, Zhang X, Yu P, Chen X, Lu P, Li M, Liu X, Li Z, Wei F, Wang K, Zheng Q, Li D. Cinobufagin Induces Cell Cycle Arrest at the G2/M Phase and Promotes Apoptosis in Malignant Melanoma Cells. Front Oncol 2019;9:853. [PMID: 31552178 DOI: 10.3389/fonc.2019.00853] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
6 Hirasaki Y, Okabe A, Fukuyo M, Rahmutulla B, Mano Y, Seki M, Hoshii T, Namiki T, Kaneda A. Cinobufagin inhibits proliferation of acute myeloid leukaemia cells by repressing c-Myc pathway-associated genes. Chem Biol Interact 2022;360:109936. [PMID: 35447139 DOI: 10.1016/j.cbi.2022.109936] [Reference Citation Analysis]
7 Majumder S, Crabtree JS, Golde TE, Minter LM, Osborne BA, Miele L. Targeting Notch in oncology: the path forward. Nat Rev Drug Discov 2021;20:125-44. [PMID: 33293690 DOI: 10.1038/s41573-020-00091-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 20] [Article Influence: 6.5] [Reference Citation Analysis]
8 Apryani E, Ali U, Wang ZY, Wu HY, Mao XF, Ahmad KA, Li XY, Wang YX. The spinal microglial IL-10/β-endorphin pathway accounts for cinobufagin-induced mechanical antiallodynia in bone cancer pain following activation of α7-nicotinic acetylcholine receptors. J Neuroinflammation 2020;17:75. [PMID: 32113469 DOI: 10.1186/s12974-019-1616-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
9 Chen R, Guan Z, Zhong X, Zhang W, Zhang Y, Tang M. Network Pharmacology Prediction: The Possible Mechanisms of Cinobufotalin against Osteosarcoma. Computational and Mathematical Methods in Medicine 2022;2022:1-9. [DOI: 10.1155/2022/3197402] [Reference Citation Analysis]
10 Jing Z, Ni R, Wang J, Lin X, Fan D, Wei Q, Zhang T, Zheng Y, Cai H, Liu Z. Practical strategy to construct anti-osteosarcoma bone substitutes by loading cisplatin into 3D-printed titanium alloy implants using a thermosensitive hydrogel. Bioact Mater 2021;6:4542-57. [PMID: 34027239 DOI: 10.1016/j.bioactmat.2021.05.007] [Reference Citation Analysis]
11 Pan Z, Luo Y, Xia Y, Zhang X, Qin Y, Liu W, Li M, Liu X, Zheng Q, Li D. Cinobufagin induces cell cycle arrest at the S phase and promotes apoptosis in nasopharyngeal carcinoma cells. Biomed Pharmacother 2020;122:109763. [PMID: 31918288 DOI: 10.1016/j.biopha.2019.109763] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]